Nature Cell Co. Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Seoul Korea, Republic of (1960)

Organization Overview

First Clinical Trial
2016
NCT02674399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Nature Cell Co. Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

allogeneic adipose derived mesenchymal stem cell (2 trials)

Drugs in Phase 2 Trials (3)

astrostem (2 trials)

donepezil (aricept) (1 trial)

hyaluronic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Pneumonia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4